ResMed Return on Investment 2010-2025 | RMD
Current and historical return on investment (ROI) values for ResMed (RMD) over the last 10 years.
| ResMed ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $1.61B | $6.21B | 27.36% |
| 2024-12-31 | $1.56B | $5.92B | 27.17% |
| 2024-09-30 | $1.42B | $5.86B | 24.93% |
| 2024-06-30 | $1.32B | $5.56B | 23.48% |
| 2024-03-31 | $1.21B | $5.63B | 21.59% |
| 2023-12-31 | $1.14B | $5.70B | 20.38% |
| 2023-09-30 | $1.15B | $5.60B | 20.63% |
| 2023-06-30 | $1.13B | $5.56B | 21.75% |
| 2023-03-31 | $1.11B | $5.51B | 22.95% |
| 2022-12-31 | $1.05B | $5.53B | 23.46% |
| 2022-09-30 | $1.01B | $4.22B | 25.18% |
| 2022-06-30 | $1.00B | $4.13B | 25.46% |
| 2022-03-31 | $0.99B | $3.95B | 26.13% |
| 2021-12-31 | $0.98B | $3.81B | 26.76% |
| 2021-09-30 | $0.95B | $3.82B | 26.26% |
| 2021-06-30 | $0.90B | $3.53B | 25.18% |
| 2021-03-31 | $0.89B | $3.43B | 24.43% |
| 2020-12-31 | $0.88B | $3.68B | 23.97% |
| 2020-09-30 | $0.86B | $3.72B | 23.53% |
| 2020-06-30 | $0.81B | $3.66B | 22.89% |
| 2020-03-31 | $0.71B | $3.62B | 20.49% |
| 2019-12-31 | $0.65B | $3.55B | 19.10% |
| 2019-09-30 | $0.61B | $3.33B | 18.44% |
| 2019-06-30 | $0.58B | $3.33B | 18.93% |
| 2019-03-31 | $0.61B | $3.35B | 21.54% |
| 2018-12-31 | $0.58B | $3.14B | 21.70% |
| 2018-09-30 | $0.57B | $2.42B | 30.06% |
| 2018-06-30 | $0.54B | $2.33B | 26.20% |
| 2018-03-31 | $0.52B | $2.88B | 23.24% |
| 2017-12-31 | $0.49B | 21.60% | |
| 2017-09-30 | $0.44B | $3.07B | 15.17% |
| 2017-06-30 | $0.43B | $3.04B | 15.06% |
| 2017-03-31 | $0.42B | $3.02B | 15.42% |
| 2016-12-31 | $0.41B | $2.58B | 16.72% |
| 2016-09-30 | $0.43B | $2.65B | 18.38% |
| 2016-06-30 | $0.43B | $2.57B | 20.04% |
| 2016-03-31 | $0.41B | $2.11B | 20.80% |
| 2015-12-31 | $0.41B | $1.93B | 21.21% |
| 2015-09-30 | $0.41B | $1.96B | 20.95% |
| 2015-06-30 | $0.41B | $1.89B | 20.62% |
| 2015-03-31 | $0.41B | $2.00B | 20.09% |
| 2014-12-31 | $0.41B | $2.04B | 19.82% |
| 2014-09-30 | $0.40B | $2.03B | 19.54% |
| 2014-06-30 | $0.41B | $2.06B | 20.47% |
| 2014-03-31 | $0.39B | $2.09B | 21.06% |
| 2013-12-31 | $0.38B | $2.08B | 21.49% |
| 2013-09-30 | $0.37B | $1.69B | 20.83% |
| 2013-06-30 | $0.35B | $1.61B | 19.14% |
| 2013-03-31 | $0.36B | $1.77B | 18.73% |
| 2012-12-31 | $0.34B | $2.05B | 17.57% |
| 2012-09-30 | $0.31B | $1.97B | 16.85% |
| 2012-06-30 | $0.30B | $1.86B | 16.46% |
| 2012-03-31 | $0.27B | $1.84B | 15.24% |
| 2011-12-31 | $0.26B | $1.79B | 14.72% |
| 2011-09-30 | $0.26B | $1.68B | 19.95% |
| 2011-06-30 | $0.27B | $1.83B | 29.88% |
| 2011-03-31 | $0.27B | $1.74B | 61.73% |
| 2010-12-31 | $0.27B | 78.12% | |
| 2010-09-30 | $0.25B | 37.44% | |
| 2010-06-30 | $0.24B | 24.03% | |
| 2010-03-31 | $0.23B | $1.36B | 17.62% |
| 2009-12-31 | $0.22B | $1.35B | 18.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.941B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.137B | 27.79 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $145.939B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $128.884B | 0.00 |
| Medtronic (MDT) | Ireland | $105.694B | 14.98 |
| Haleon (HLN) | United Kingdom | $51.038B | 29.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.182B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $32.753B | 15.55 |
| Agilent Technologies (A) | United States | $32.296B | 20.98 |
| Terumo (TRUMY) | Japan | $27.790B | 36.10 |
| Insulet (PODD) | United States | $22.791B | 89.46 |
| Koninklijke Philips (PHG) | Netherlands | $21.581B | 15.51 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.467B | 11.86 |
| Baxter (BAX) | United States | $15.754B | 11.76 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.622B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.194B | 21.55 |
| Lantheus Holdings (LNTH) | United States | $5.225B | 13.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.175B | 18.65 |
| Perrigo (PRGO) | Ireland | $3.730B | 9.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Haemonetics (HAE) | United States | $3.259B | 14.85 |
| Envista Holdings (NVST) | United States | $3.129B | 26.00 |
| GN Store Nord (GNNDY) | Denmark | $2.215B | 18.35 |
| QuidelOrtho (QDEL) | United States | $2.080B | 14.30 |
| LeMaitre Vascular (LMAT) | United States | $1.832B | 40.94 |
| AtriCure (ATRC) | United States | $1.687B | 0.00 |
| Neogen (NEOG) | United States | $1.348B | 17.25 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.165B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| BioLife Solutions (BLFS) | United States | $1.060B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.000B | 12.78 |
| InMode (INMD) | Israel | $0.922B | 9.29 |
| CeriBell (CBLL) | United States | $0.615B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.604B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.582B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.502B | 4.17 |
| Tilray Brands (TLRY) | Canada | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.461B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.333B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| ZimVie (ZIMV) | United States | $0.250B | 11.35 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Cerus (CERS) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| Biote (BTMD) | United States | $0.197B | 5.53 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.44 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.52 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Agape ATP (ATPC) | $0.088B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |